The idea that low-fat diets, such as those recommended for
so many years by the US government and the American Heart Association (AHA),
are effective at preventing atherosclerotic cardiovascular disease has now been
generally discredited. Over the past several decades, clinical studies in which
dietary fat was restricted to less than 25% of daily calories have failed to
demonstrate a cardiovascular benefit. A few years ago, the AHA quietly dropped
its low-fat diet recommendation.
There is, however, one glaring exception to the evidence
that low-fat diets are not effective at preventing heart disease - the Ornish
diet. The Ornish diet (and similar diets) not only restrict dietary fat quite
severely (to less than 10% of daily calories), but also require any ingested
fats come from purely plant sources. In both the medical literature and in the
popular press, the Ornish diet is held out as having been proven effective in
preventing the progression of coronary artery disease (CAD), and even in
facilitating an actual improvement in coronary artery plaques.
Is this true? Despite the fact that the AHA-style
fat-restricted diet has failed to prevent atherosclerosis, does the
ultra-restrictive Ornish-type diet work?
The Ornish Study
All of the books, websites, TV appearances, speeches, editorials,
documentaries, etc., that tout the effectiveness of the Ornish diet can be
traced back to a single clinical trial, the Lifestyle Heart Trial, conducted in
the 1980s and 1990s by Dr. Dean Ornish and his group at the California Pacific
Medical Center in San Franciso.
They enrolled 48 patients (45 of whom were men) who had
known CAD. Twenty-eight were randomized to a special program of comprehensive
lifestyle changes which included the severely fat-restricted, vegetarian Ornish
diet, along with smoking cessation, meditation and stress management, and a
formal exercise program. The other 20 patients, the control group, did not
receive this intensive lifestyle management program. During a 5-year follow-up
period, patients in the study group experienced significantly fewer cardiac
events than those in the control group, and also had a 3% regression in the
size of their coronary artery plaques (as compared to an increase in plaques in
the control group).
It is a little disturbing, to me at least, to consider that
the Ornish empire is built on this one small study. For one thing, there was a
substantial drop-out of patients during this study, and these patients were
subsequently excluded from analysis. Drop-outs are especially important in
small studies since the loss of data can significantly impact the results. The
small size of the study also produced substantial baseline differences between
the two groups. For instance, the control group had higher total cholesterol
and LDL cholesterol values, and were older and thinner than the treatment
group. Again, these sorts of problems are common to small clinical trials, and
they create inherent difficulties in interpreting differences in outcomes
between the groups.
More importantly, the idea that the Ornish diet causes
reversal of atherosclerosis is quite problematic. Comparing results from
different 2-D angiograms made at different times (as was done in this study) is
famously fraught with error, since tiny differences in the angles of the
recorded images can yield big differences in the calculation of plaque size.
Even if such measurements were precise - and they are far from precise -
accurately detecting a 3% change in plaque size cannot be accomplished with any
degree of confidence with 2-D angiography. This limitation is not the fault of
the researchers - better techniques did not exist in those days. (They do exist
today, should the Ornish study ever be repeated.) But this limitation is
nonetheless critical, and calls into great question the frequent claims made by
proponents that the Ornish diet reverses atherosclerosis. Such methodological
limitations would make it very difficult for a study like this even to be
accepted for publication today in a peer-reviewed medical journal.
Finally, even if the reported results of the Ornish study
did turn out to be accurate, it is impossible to attribute any of this benefit
specifically to the Ornish diet. This is because the other three interventions
applied to the study group (smoking cessation, stress management, and regular
exercise) are all known to improve cardiac outcomes in patients with CAD. The
improved outcomes seen in the treatment group are explainable by these other
three interventions; any benefit from the Ornish diet itself cannot be inferred
in this trial.
There is little doubt that an aggressive lifestyle
management program is a useful thing in patients with CAD, and the Ornish study
(which, after all, was called the Lifestyle Heart Trial, and not the Ornish
Diet Trial) certainly employed aggressive lifestyle changes. But especially in
view of the general failure of low-fat diets to improve cardiac outcomes in
other studies, substantial doubt exists as to how much benefit the dietary
component of this study contributed to the favorable outcomes. A well designed
clinical trial would be required to answer this question.
The Bottom Line on the Ornish Diet
Based on the results of the Ornish study - the small
randomized trial upon which all the famous claims regarding the Ornish diet are
based - the notion that an ultra-low fat vegetarian diet improves CAD should be
regarded as an intriguing hypothesis. But that’s all it is - an unproven
hypothesis, and not a proven fact. I for one think somebody ought to design a
study to see whether the hypothesis is true.
And if you are going to follow an Ornish-type diet, be
careful of that vegetable oil.
No comments:
Post a Comment